Four clinical organizations jointly release an advisory with evidence-based nutrition and lifestyle interventions to enhance GLP-1 treatment outcomes for obesity.

Eli Lilly has been experiencing strong growth lately due to its impressive GLP-1 drugs. Eli Lilly (NYSE: LLY) has been a ...